tiprankstipranks
Advertisement
Advertisement
Eli Lilly (LLY) Is Investing Another $750 Million in Its U.S. Manufacturing Capacity
PremiumMarket NewsEli Lilly (LLY) Is Investing Another $750 Million in Its U.S. Manufacturing Capacity
2d ago
Goldman Sachs Forecasts Weak Obesity Pill Sales from Eli Lilly (LLY)
Premium
Market News
Goldman Sachs Forecasts Weak Obesity Pill Sales from Eli Lilly (LLY)
4d ago
Alkermes price target raised to $65 from $43 at Piper Sandler
Premium
The Fly
Alkermes price target raised to $65 from $43 at Piper Sandler
4d ago
Eli Lilly notes retatrutide met primary endpoint in TRIUMPH-2, TRIUMPH-3 trials
PremiumThe FlyEli Lilly notes retatrutide met primary endpoint in TRIUMPH-2, TRIUMPH-3 trials
9d ago
Real-World Diabetes Data: What Eli Lilly’s EMPRISE Update Means for LLY Investors
Premium
Company Announcements
Real-World Diabetes Data: What Eli Lilly’s EMPRISE Update Means for LLY Investors
10d ago
Trump Trade: U.S. to impose 100% tariff on imported generic drugs
Premium
The Fly
Trump Trade: U.S. to impose 100% tariff on imported generic drugs
10d ago
Novo Nordisk files lawsuit against ‘misleading’ GLP-1 ads from Eli Lilly
PremiumThe FlyNovo Nordisk files lawsuit against ‘misleading’ GLP-1 ads from Eli Lilly
11d ago
Novo Nordisk suing Eli Lilly over weight-loss ads, Bloomberg reports
Premium
The Fly
Novo Nordisk suing Eli Lilly over weight-loss ads, Bloomberg reports
11d ago
Alkermes price target raised to $63 from $45 at Stifel
Premium
The Fly
Alkermes price target raised to $63 from $45 at Stifel
12d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100